ASO Visual Abstract: Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score—A Multicenter Study
- 4 October 2024
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (13) , 9065-9066